BLTE - Company ID 0001889109
The table below shows BELITE BIO, INC's balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash & equivalents | $352.93M | $31.68M | $88.16M | $42.09M |
| Short-term investments | - | - | - | - |
| Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $494.27M | $147.07M | $89.94M | $42.81M |
| Property, plant & equipment | $344.00K | $444.00K | $490.00K | $541.00K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | - | - | - | - |
| Total assets | $780.56M | $152.13M | $94.64M | $44.27M |
| Accounts payable | - | - | - | - |
| Total current liabilities | $9.88M | $6.05M | $3.63M | $2.10M |
| Long-term debt | - | - | - | - |
| Total liabilities | $10.07M | $6.31M | $4.21M | $2.77M |
| Retained earnings | -$185.26M | -$107.65M | -$71.50M | -$39.87M |
| Total equity | $770.49M | $145.82M | $90.43M | $41.50M |